ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

New Recommendations made For Radiation Protection Standards

August 14, 1987

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.

May 13, 1994

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

NCI Spearheads Asbestos Alert

June 16, 1978